Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Peer power: new study tests if support buddies boost HIV treatment success

NCT ID NCT06501781

First seen Nov 01, 2025

Summary

This study tests whether trained peer recovery specialists can help Black individuals with HIV or at high risk stay on track with long-acting injectable HIV medications and reduce substance use. 186 participants will either get the peer support program or standard care, and researchers will track medication adherence and substance use over 12 months. The goal is to find a practical, affordable way to improve health outcomes in underserved communities.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SUBSTANCE USE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Baltimore Safe Haven

    RECRUITING

    Baltimore, Maryland, 21218, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • HIPS (Harm reduction drop-in center)

    RECRUITING

    Washington D.C., District of Columbia, 20002, United States

    Contact

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Peer behavioral activation and problem-solving intervention

What this could lead to

If it works, this could provide a scalable, cost-effective model to improve HIV medication adherence and reduce substance use in underserved Black communities.

What could go wrong

This is a relatively small, early-stage trial (186 participants) testing a behavioral intervention, not a drug. Results may not generalize widely, and the intervention's success depends on peer delivery fidelity.

Conditions

The condition(s) this trial relates to.

HIV infectious disease substance-related disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.